Cite
HARVARD Citation
Borgwardt, L. et al. (2018). Efficacy and safety of Velmanase alfa in the treatment of patients with alpha‐mannosidosis: results from the core and extension phase analysis of a phase III multicentre, double‐blind, randomised, placebo‐controlled trial. Journal of inherited metabolic disease. 41 (6), pp. 1215-1223. [Online].